$PSNL
Personalis, Inc.

2024 Q1 Form 10-K Financial Statement

#000095017024022097 Filed on February 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $19.53M $19.68M $73.48M
YoY Change 3.53% 17.66% 12.97%
Cost Of Revenue $14.03M $14.47M $55.27M
YoY Change -0.69% 0.42% 6.92%
Gross Profit $5.493M $5.205M $18.21M
YoY Change 16.13% 125.13% 36.39%
Gross Profit Margin 28.13% 26.45% 24.78%
Selling, General & Admin $11.60M $11.52M $49.73M
YoY Change -17.7% -35.36% -22.27%
% of Gross Profit 211.21% 221.4% 273.1%
Research & Development $12.77M $13.61M $64.78M
YoY Change -22.94% -17.84% -0.21%
% of Gross Profit 232.5% 261.54% 355.76%
Depreciation & Amortization $2.800M $2.907M $11.30M
YoY Change 0.0% -1.66% 34.52%
% of Gross Profit 50.97% 55.85% 62.06%
Operating Expenses $24.37M $25.14M $114.5M
YoY Change -20.53% -26.92% -11.16%
Operating Profit -$18.88M -$19.93M -$109.9M
YoY Change -36.7% -37.88% -4.84%
Interest Expense $9.000K $1.468M $110.0K
YoY Change -80.85% 31.9% -45.27%
% of Operating Profit
Other Income/Expense, Net $4.569M -$4.075M -$4.068M
YoY Change -17673.08% 4530.68% -6768.85%
Pretax Income -$12.96M -$26.58M -$108.2M
YoY Change -54.75% -14.43% -4.47%
Income Tax $7.000K $5.000K $83.00K
% Of Pretax Income
Net Earnings -$12.97M -$26.58M -$108.3M
YoY Change -54.75% -14.43% -4.43%
Net Earnings / Revenue -66.42% -135.12% -147.38%
Basic Earnings Per Share -$0.26 -$2.25
Diluted Earnings Per Share -$0.26 -$0.54 -$2.25
COMMON SHARES
Basic Shares Outstanding 50.50M 49.03M 48.18M
Diluted Shares Outstanding 50.68M 48.18M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.42M $114.2M $114.2M
YoY Change -35.93% -31.9% -31.9%
Cash & Equivalents $43.98M $56.98M $56.98M
Short-Term Investments $51.44M $57.20M $57.20M
Other Short-Term Assets $4.908M $4.361M $4.361M
YoY Change -34.66% -35.94% -35.94%
Inventory $8.767M $10.47M $10.47M
Prepaid Expenses
Receivables $11.35M $17.73M $17.73M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $120.4M $146.7M $146.7M
YoY Change -34.1% -26.52% -26.52%
LONG-TERM ASSETS
Property, Plant & Equipment $54.53M $57.37M $75.22M
YoY Change -11.26% -7.38% -14.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.793M $3.137M $3.137M
YoY Change -30.02% -31.6% -31.6%
Total Long-Term Assets $74.84M $78.36M $78.36M
YoY Change -16.3% -15.75% -15.75%
TOTAL ASSETS
Total Short-Term Assets $120.4M $146.7M $146.7M
Total Long-Term Assets $74.84M $78.36M $78.36M
Total Assets $195.3M $225.1M $225.1M
YoY Change -28.25% -23.1% -23.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.179M $14.92M $14.92M
YoY Change -16.0% 16.07% 16.07%
Accrued Expenses $1.126M $858.0K $21.44M
YoY Change 10.61% -49.53% 33.14%
Deferred Revenue $3.526M $3.288M
YoY Change 37.57% 160.13%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.654M $1.646M $1.646M
YoY Change -26.72% -25.79% -25.79%
Total Short-Term Liabilities $31.37M $47.23M $47.23M
YoY Change -8.11% 42.57% 42.57%
LONG-TERM LIABILITIES
Long-Term Debt $925.0K $1.234M $1.234M
YoY Change 139.64% 226.46% 226.46%
Other Long-Term Liabilities $3.022M $5.161M $47.19M
YoY Change -26.22% 1226.74% 14.95%
Total Long-Term Liabilities $3.022M $5.161M $48.42M
YoY Change -26.22% 1226.74% 16.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.37M $47.23M $47.23M
Total Long-Term Liabilities $3.022M $5.161M $48.42M
Total Liabilities $74.58M $95.66M $95.66M
YoY Change -5.05% 28.29% 28.29%
SHAREHOLDERS EQUITY
Retained Earnings -$481.7M -$468.7M
YoY Change 23.8% 30.05%
Common Stock $602.5M $598.4M
YoY Change 3.32% 3.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $120.7M $129.4M $129.4M
YoY Change
Total Liabilities & Shareholders Equity $195.3M $225.1M $225.1M
YoY Change -28.25% -23.1% -23.1%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$12.97M -$26.58M -$108.3M
YoY Change -54.75% -14.43% -4.43%
Depreciation, Depletion And Amortization $2.800M $2.907M $11.30M
YoY Change 0.0% -1.66% 34.52%
Cash From Operating Activities -$20.41M -$13.42M -$56.26M
YoY Change 29.65% -19.95% -19.9%
INVESTING ACTIVITIES
Capital Expenditures $104.0K $3.524M $10.91M
YoY Change -97.25% -63.05% -78.13%
Acquisitions
YoY Change
Other Investing Activities $6.405M -$8.114M $24.01M
YoY Change -63.55% -125.85% -76.56%
Cash From Investing Activities $6.301M -$11.64M $13.10M
YoY Change -54.32% -153.26% -75.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.513M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.129M 9.816M 11.03M
YoY Change 1820.94% 707.54%
NET CHANGE
Cash From Operating Activities -20.41M -13.42M -56.26M
Cash From Investing Activities 6.301M -11.64M 13.10M
Cash From Financing Activities 1.129M 9.816M 11.03M
Net Change In Cash -13.00M -15.24M -32.14M
YoY Change 564.78% -372.14% 95.32%
FREE CASH FLOW
Cash From Operating Activities -$20.41M -$13.42M -$56.26M
Capital Expenditures $104.0K $3.524M $10.91M
Free Cash Flow -$20.52M -$16.94M -$67.17M
YoY Change 5.09% -35.58% -44.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001527753
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38943
CY2023 dei Entity Registrant Name
EntityRegistrantName
Personalis, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-5411038
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
6600 Dumbarton Circle
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94555
CY2023 dei City Area Code
CityAreaCode
650
CY2023 dei Local Phone Number
LocalPhoneNumber
752-1300
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
CY2023 dei Trading Symbol
TradingSymbol
PSNL
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
90600000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50503889
CY2023 dei Auditor Firm
AuditorFirmId
243
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56984000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89128000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
57195000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
78530000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17730000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16642000
CY2023Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
10474000
CY2022Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
8591000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4361000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6808000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
146744000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
199699000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57366000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61935000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17852000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26480000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3137000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4586000
CY2023Q4 us-gaap Assets
Assets
225099000
CY2022Q4 us-gaap Assets
Assets
292700000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14920000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12854000
CY2023Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
23941000
CY2022Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
19013000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3288000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1264000
CY2023Q4 psnl Warrant Liability Current
WarrantLiabilityCurrent
5085000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47234000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33131000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38321000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41041000
CY2023Q4 psnl Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
4942000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5161000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
389000
CY2023Q4 us-gaap Liabilities
Liabilities
95658000
CY2022Q4 us-gaap Liabilities
Liabilities
74561000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50480694
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50480694
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46707084
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46707084
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
598364000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
579456000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-222000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-912000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-468706000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-360410000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
129441000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
218139000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
225099000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
292700000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73481000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65047000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85494000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
55273000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
51697000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
53837000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64776000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64912000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49312000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49726000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63969000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47698000
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
5565000
CY2023 us-gaap Restructuring Charges
RestructuringCharges
8077000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
183417000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
180578000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
150847000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-109936000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-115531000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-65353000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
5901000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
2396000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
367000
CY2023 us-gaap Interest Expense
InterestExpense
110000
CY2022 us-gaap Interest Expense
InterestExpense
201000
CY2021 us-gaap Interest Expense
InterestExpense
184000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4068000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
61000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-42000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-108213000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-113275000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65212000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-108296000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-113315000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-65226000
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.25
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.25
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.48
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.48
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48175201
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48175201
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45704805
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45704805
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43886730
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43886730
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-108296000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-113315000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-65226000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-277000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
49000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
671000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-469000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-237000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107606000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-114061000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65414000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
194945000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
161916000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2096000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2380000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14378000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
49000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-237000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-65226000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
310301000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1011000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1455000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19433000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-277000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-469000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-113315000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
218139000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3513000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1344000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14051000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
19000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
671000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-108296000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
129441000
CY2023 us-gaap Profit Loss
ProfitLoss
-108296000
CY2022 us-gaap Profit Loss
ProfitLoss
-113315000
CY2021 us-gaap Profit Loss
ProfitLoss
-65226000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
14051000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
19433000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
14378000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11296000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8432000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6014000
CY2023 psnl Noncash Lease Expense
NoncashLeaseExpense
1859000
CY2022 psnl Noncash Lease Expense
NoncashLeaseExpense
4446000
CY2021 psnl Noncash Lease Expense
NoncashLeaseExpense
2950000
CY2023 psnl Amortization Of Premium Discount On Short Term Investments
AmortizationOfPremiumDiscountOnShortTermInvestments
2000000
CY2022 psnl Amortization Of Premium Discount On Short Term Investments
AmortizationOfPremiumDiscountOnShortTermInvestments
-57000
CY2021 psnl Amortization Of Premium Discount On Short Term Investments
AmortizationOfPremiumDiscountOnShortTermInvestments
-2031000
CY2023 psnl Noncash Restructuring And Other Charges
NoncashRestructuringAndOtherCharges
3605000
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
5565000
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-153000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-103000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-169000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1088000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1825000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12118000
CY2023 psnl Increase Decrease In Inventories And Other Deferred Costs
IncreaseDecreaseInInventoriesAndOtherDeferredCosts
1934000
CY2022 psnl Increase Decrease In Inventories And Other Deferred Costs
IncreaseDecreaseInInventoriesAndOtherDeferredCosts
2982000
CY2021 psnl Increase Decrease In Inventories And Other Deferred Costs
IncreaseDecreaseInInventoriesAndOtherDeferredCosts
-29000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3748000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-484000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2658000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5178000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3089000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1457000
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
742000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1479000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3365000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5952000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2718000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-17052000
CY2023 psnl Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
894000
CY2022 psnl Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
12811000
CY2021 psnl Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-962000
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-10000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-419000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-291000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56258000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70233000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70828000
CY2023 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
103945000
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
121490000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
267128000
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
127955000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
223923000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
213083000
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5059000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10911000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49896000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11083000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13099000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
52537000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60069000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
162258000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
342000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3513000
CY2023 psnl Proceeds From Payment Agreements With Financing Entity
ProceedsFromPaymentAgreementsWithFinancingEntity
3438000
CY2022 psnl Proceeds From Payment Agreements With Financing Entity
ProceedsFromPaymentAgreementsWithFinancingEntity
1194000
CY2021 psnl Proceeds From Payment Agreements With Financing Entity
ProceedsFromPaymentAgreementsWithFinancingEntity
5167000
CY2023 psnl Repayments Of Payment Agreements With Financing Entity
RepaymentsOfPaymentAgreementsWithFinancingEntity
3264000
CY2022 psnl Repayments Of Payment Agreements With Financing Entity
RepaymentsOfPaymentAgreementsWithFinancingEntity
2293000
CY2021 psnl Repayments Of Payment Agreements With Financing Entity
RepaymentsOfPaymentAgreementsWithFinancingEntity
1857000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1344000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2465000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4474000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11031000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1366000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
169700000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-16000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-127000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32144000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16457000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38850000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90918000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107375000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68525000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58774000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90918000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107375000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56984000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89128000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105585000
CY2023Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1790000
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1790000
CY2021Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1790000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58774000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90918000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107375000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
64000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
47000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
39000
CY2023 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
104000
CY2022 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
3917000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
3006000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Arial;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The estimates include, but are not limited to, revenue recognition, useful lives assigned to long-lived assets, discount rates for lease accounting, the valuation of stock options, the valuation of common stock warrants, provisions for income taxes, and fair value of lease right-of-use assets. Actual results could differ from these estimates, and such differences could be material to the Company’s consolidated financial position and results of operations.</span></p>
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9008000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7761000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5391000
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
1646000
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
2218000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
858000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73481000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65047000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85494000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16642000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18468000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1264000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3982000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1264000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3982000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17730000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16642000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3288000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1264000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3928000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7216000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1264000
CY2023 psnl Revenue Performance Obligation Unsatisfied Service Period Description
RevenuePerformanceObligationUnsatisfiedServicePeriodDescription
unfulfilled services under contracts with an original expected duration of more than one year
CY2023 psnl Contract With Customer Unsatisfied Services Revenue
ContractWithCustomerUnsatisfiedServicesRevenue
5700000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1800000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3900000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3500000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
19100000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1700000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5661000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6384000
CY2023Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
4813000
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
2207000
CY2023Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
10474000
CY2022Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
8591000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95034000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88861000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37668000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26926000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57366000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61935000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11300000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8400000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6000000
CY2023Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1800000
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1800000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12816000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
311000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
543000
CY2023Q4 psnl Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
512000
CY2022Q4 psnl Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
30000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
37000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
123000
CY2023Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
23941000
CY2022Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
19013000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0
CY2023 psnl Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2027-11
CY2023Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
31280
CY2021Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
14710
CY2021 psnl Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2022-12
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
not extended
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2023 psnl Operating Lease Terminate Cost
OperatingLeaseTerminateCost
0
CY2023 psnl Remaining Lease Liability And Derecognized Of Operating Lease Liabilities And Right Of Use Assets
RemainingLeaseLiabilityAndDerecognizedOfOperatingLeaseLiabilitiesAndRightOfUseAssets
600000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8134000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8057000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7230000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7189000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5215000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
42798000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
78623000
CY2023Q4 psnl Lessee Operating Lease Liability Discount On Obligation Amount
LesseeOperatingLeaseLiabilityDiscountOnObligationAmount
32541000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
46082000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7761000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38321000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
6000000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
4400000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
3300000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1300000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3100000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46500000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
6793000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
8530000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
5009000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
198000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
122000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
364000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
1828000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
1411000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
1152000
CY2023 us-gaap Lease Cost
LeaseCost
8819000
CY2022 us-gaap Lease Cost
LeaseCost
10063000
CY2021 us-gaap Lease Cost
LeaseCost
6525000
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
5600000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2023 us-gaap Restructuring Charges
RestructuringCharges
8077000
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
4948000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
3129000
CY2023Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
100
CY2023Q4 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
60
CY2023Q4 us-gaap Restructuring And Related Activities Completion Date
RestructuringAndRelatedActivitiesCompletionDate
2024-03-31
CY2023 psnl Restructuring Expenses Related To Disposals Of Fixed Assets And Impairment Of Other Assets
RestructuringExpensesRelatedToDisposalsOfFixedAssetsAndImpairmentOfOtherAssets
600000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
Options granted to new hires generally vest over a four-year period, with 25% vesting at the end of one year and the remaining vesting monthly thereafter. Options granted as merit awards generally vest monthly over a three- or four-year period
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2023Q4 psnl Closing Price Of Common Stock
ClosingPriceOfCommonStock
2.1
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.81
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.21
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.14
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7200000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7847
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7931
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6837
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7768
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6797
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.699
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0347
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0466
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0162
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0423
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0062
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0139
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14051000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19433000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14378000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14051000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19433000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14378000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-108296000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-113315000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-65226000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48175201
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48175201
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45704805
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45704805
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43886730
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43886730
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.25
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.25
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.48
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.48
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-31000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-29000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16792093
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9121354
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7190482
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-106833000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-113558000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-65415000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1380000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
283000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
203000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-108213000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-113275000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65212000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-9000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
35000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
66000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
43000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
29000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
71000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
43000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
54000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-31000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-29000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
54000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.07
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.06
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.09
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.26
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.36
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.03
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.01
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.03
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.03
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.02
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.03
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.02
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
83983000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
72408000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
22669000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16824000
CY2023Q4 psnl Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
22089000
CY2022Q4 psnl Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
11972000
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
362000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
38000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2883000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1914000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4614000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5197000
CY2023Q4 psnl Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
13124000
CY2022Q4 psnl Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
13455000
CY2023Q4 psnl Deferred Tax Assets Other Intangible Assets
DeferredTaxAssetsOtherIntangibleAssets
209000
CY2022Q4 psnl Deferred Tax Assets Other Intangible Assets
DeferredTaxAssetsOtherIntangibleAssets
267000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
132000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
236000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
150065000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
122311000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
144861000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
114483000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5204000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7828000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
113000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
108000
CY2023Q4 psnl Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
5084000
CY2022Q4 psnl Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
7659000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5197000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7767000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
61000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
30400000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
32900000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4240000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3066000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
162000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1299000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1174000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5701000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4240000
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2023 dei Auditor Name
AuditorName
BDO USA, P.C.
CY2023 dei Auditor Location
AuditorLocation
San Jose, California

Files In Submission

Name View Source Status
0000950170-24-022097-index-headers.html Edgar Link pending
0000950170-24-022097-index.html Edgar Link pending
0000950170-24-022097.txt Edgar Link pending
0000950170-24-022097-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img80089866_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
psnl-20231231.htm Edgar Link pending
psnl-20231231.xsd Edgar Link pending
psnl-ex10_12.htm Edgar Link pending
psnl-ex10_13.htm Edgar Link pending
psnl-ex10_14.htm Edgar Link pending
psnl-ex10_15.htm Edgar Link pending
psnl-ex10_4.htm Edgar Link pending
psnl-ex10_5.htm Edgar Link pending
psnl-ex10_6.htm Edgar Link pending
psnl-ex21_1.htm Edgar Link pending
psnl-ex23_1.htm Edgar Link pending
psnl-ex23_2.htm Edgar Link pending
psnl-ex31_1.htm Edgar Link pending
psnl-ex31_2.htm Edgar Link pending
psnl-ex32_1.htm Edgar Link pending
psnl-ex32_2.htm Edgar Link pending
psnl-ex97.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
psnl-20231231_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable